Emergency Contraception - User's Profile

Emergency Contraception - Observational Study of User's Profile

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01771016

Enrollment

729

Registered

2013-01-18

Start date

2006-01-31

Completion date

2009-08-31

Last updated

2013-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postcoital Contraception

Keywords

Emergency contraception, Emergency hormonal contraception, Community pharmacies, Pharmaceutical care, Time to access, Written assessments, Switzerland

Brief summary

Retrospective analysis of requests of emergency hormonal contraception using pharmacy protocols registered in 2003 and 2006.

Detailed description

In 2002, Levonorgestrel was introduced in Switzerland for emergency hormonal contraception (EC) without prescription ('pharmacist only'). In 2003, a first analysis of requests of EC showed that the dispensing of EC through pharmacies could successfully be implemented (Lemke et al 2004). This study was repeated three years later with the aim to explore whether the user's profile has changed after introduction of a low threshold access to EC.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* women seaking emergency hormonal contraception

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Sexual and protective behaviour	2 years	questions of interest: Did you forget to take the pill?, Did you have any other unprotected sexual intercourse since your last period? and Have you ever taken the morning-after pill before?

Secondary

Measure	Time frame
elapsed hours since unprotected intercourse	1 month

Other

Measure	Time frame	Description
pharmacy status and care activity	1 month	pharmacy status (walk-in or emergency), and the three activities of the pharmacists (performance of a pregnancy test, delivery of EHC, referral to a physician).

Outcome results